Former vice president highlights 75% drop in liver cancer deaths and 70% reduction in cervical cancer incidence and mortality ...

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (the "Company"), comments on the new COVID Vaccine policy adopted by the US FDA.The new FDA COVID ...

The diagnosis of an HCV infection was made on the basis of the presence of anti-HCV antibodies (Ortho HCV 3.0 ELISA test system with Enhanced SAVe, Ortho Clinical Diagnostics, Raritan, NJ, USA) and ...

Explore how CRISPR could become a powerful antiviral tool against HIV, Hepatitis B, HPV, and more, based on emerging research.

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...

An oral presentation at ASCO & EHA Congress from the CARTITUDE-1 study highlighting heavily pre-treated patients that remain alive and progression-free for more than 5 years after a single CARVYKTI® ...

Competing hepatitis C combination drugs from AbbVie and Gilead are now approved in the EU, as the companies aim to treat patients who cannot be cured with established regimens. AbbVie’s Maviret ...

Researchers from Ludwig Cancer Research have developed an antibody, PLT012, that targets the lipid transporter CD36 to reverse immune suppression in fat-rich tumor environments, restoring anti-tumor ...

In contrast, both a higher incidence of recurrent hepatitis C and more aggressive disease have been linked with rejection and the treatment of rejection with more potent immunosuppression.35-37 ...

This useful manuscript provides a newly curated database (termed AACDB) of antibody-antigens structural information, alongside annotations that are either taken and from the PDB, or added de-novo.

All patients positive for hepatitis-C-RNA should be referred for antiviral treatment. Also, patients who are non-immune to varicella zoster virus should be informed about the availability of ...